Andrew Perry - Jul 1, 2024 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Chief Commercial Officer
Signature
/s / Monica Roberts Thomas, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 05:34 PM
Previous filing
May 15, 2024
Next filing
Jul 8, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +35K +44.33% $0.00 114K Jul 1, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 50% on July 1, 2025 and 50% on July 1, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 12,806 shares of common stock; (ii) 3,000 RSUs from award granted on January 3, 2022; (iii) 12,075 RSUs from award granted on January 3, 2023; (iv) 17,500 RSUs from award granted on May 10, 2023; (v) 33,570 RSUs from award granted on January 3, 2024; and (vi) 35,000 RSUs from award granted on July 1, 2024.